| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 07/13/1999 | US5922600 Chicken anemia virus mutants and vaccines and uses based on the viral proteins VP1 VP2 and VP3 or sequences of that virus coding therefor |
| 07/13/1999 | US5922598 Reducing tissue immunogenicity by induction of apoptosis |
| 07/13/1999 | US5922595 Cyclic GMP phosphodiesterase |
| 07/13/1999 | US5922590 Hic-1 is a marker which can be used diagnostically, prognostically and therapeutically over the course of such disorders. |
| 07/13/1999 | US5922580 Contacting a reducing partial starch hydrolysate with a novel enzyme which forms a non-reducing saccharide in the absence of trehalose; glucoamylase and glycosidase yield trehalose when allowed to act on the non-reducing saccharide |
| 07/13/1999 | US5922573 A mutant of interleukin-ira in which atleast one amino acid residue in position91 and 109 of the sequence of wild type interleukin-ira is replaced by a residue selected from lysin, serine, glutamine, arganine, histidine and tyrosine in at 91 |
| 07/13/1999 | US5922572 Polynucleotides encoding haemopoietic maturation factor |
| 07/13/1999 | US5922571 Polynucleotides encoding a protein kinase C homolog |
| 07/13/1999 | US5922567 Two new human DNAJ-like proteins |
| 07/13/1999 | US5922566 Polynucleotide |
| 07/13/1999 | US5922563 Adhesin genes and proteins involved in trichomonas vaginalis cytoadherence |
| 07/13/1999 | US5922562 Nucleic acids encoding transferrin receptors |
| 07/13/1999 | US5922546 Human disintegrin metalloprotease KUZ gene |
| 07/13/1999 | US5922541 Method for detection of PF4A receptor nucleic acid |
| 07/13/1999 | US5922354 Methods and system for processing dispersible fine powders |
| 07/13/1999 | US5922346 A mixtures of reduced glutathione, selenium or a selenium compound for reducing free radical damage induced by tobacco products and environmental pollutants |
| 07/13/1999 | US5922329 Immunity against giardia from vaccine from isolation of exotoxin |
| 07/13/1999 | US5922327 Equine herpes virus glycoproteins |
| 07/13/1999 | US5922325 Synergistic neutralization of HIV-1 by human monoclonal antibodies and other antibodies directed against the v3 loop and the CD-4 binding site of GP-120,and the use for immunotherapy of HIV-1 infection |
| 07/13/1999 | US5922323 Transferrin receptor genes and immunogenic compositions derived therefrom |
| 07/13/1999 | US5922322 Cleaves at the gamma glycine404-alanine405 peptide bond; apply to medical equipment to inhibit thrombus formation; administering to treat restenosis post-surgery, to inhibit vascular reocclusion |
| 07/13/1999 | US5922321 Prostate-specific kallikrein |
| 07/13/1999 | US5922320 Recombinant proCVF |
| 07/13/1999 | US5922319 Methods of treating eye conditions with human leukocyte elastase (HLE) inhibitory agents |
| 07/13/1999 | US5922318 Drug protein |
| 07/13/1999 | US5922302 Detection and therapy of lesions with biotin/avidin-metal chelating protein conjugates |
| 07/13/1999 | US5922253 Production scale method of forming microparticles |
| 07/13/1999 | US5921987 Articular cartilage transplant instrument set |
| 07/13/1999 | CA2176037C Antithrombotic amidinophenylalanine and amidinopyridylalanine derivatives |
| 07/13/1999 | CA2135999C Biotherapeutic cell-coated microspheres |
| 07/13/1999 | CA2121257C Stabilised antibodies |
| 07/13/1999 | CA2044154C Method of assaying d-vanillylmandelic acid, and reagent and kit therefor |
| 07/13/1999 | CA2000153C Antidote |
| 07/13/1999 | CA1340650C Artificial gene coding for authentic human serum albumin, use thereof, and method of producing the same |
| 07/13/1999 | CA1340649C Purified follicle stimulating hormone |
| 07/13/1999 | CA1340646C Cyclic anticoagulant peptides |
| 07/13/1999 | CA1340641C Recombinant lymphotoxin |
| 07/08/1999 | WO1999034217A1 Reagents specific for st2l and uses therefor |
| 07/08/1999 | WO1999034017A1 Reagents and methods useful for detecting diseases of the breast |
| 07/08/1999 | WO1999034004A2 Metastatic breast and colon cancer regulated genes |
| 07/08/1999 | WO1999034000A1 IKKβ REGULATES TRANSCRIPTION FACTORS |
| 07/08/1999 | WO1999033999A1 Mitogen-activated protein kinase kinase 7 (mkk7) |
| 07/08/1999 | WO1999033998A2 Regulatory dna sequences of the human catalytic telomerase sub-unit gene, diagnostic and therapeutic use thereof |
| 07/08/1999 | WO1999033992A1 Murine intracisternal a particle constitutive transport elements and uses thereof |
| 07/08/1999 | WO1999033989A2 Rantes mutants and therapeutic applications thereof |
| 07/08/1999 | WO1999033988A1 A process for preparing human proinsulin |
| 07/08/1999 | WO1999033985A2 C1F150/hTAFII150 IS NECESSARY FOR CELL CYCLE PROGRESSION |
| 07/08/1999 | WO1999033981A2 Human signal peptide-containing proteins |
| 07/08/1999 | WO1999033979A2 Bone marrow secreted proteins and polynucleotides |
| 07/08/1999 | WO1999033978A1 Novel guanosine triphosphate (gtp)-binding protein conjugate type receptor proteins |
| 07/08/1999 | WO1999033977A1 Tumor antigen protein, gene thereof, and utilization thereof |
| 07/08/1999 | WO1999033976A1 Polypeptide, their production and use |
| 07/08/1999 | WO1999033974A1 Serine proteinase inhibitors |
| 07/08/1999 | WO1999033971A1 Oligomers that bind to ku protein |
| 07/08/1999 | WO1999033970A1 Medicinal compositions for treating or preventing influenza and novel capped oligoribonucleotides |
| 07/08/1999 | WO1999033967A2 Novel nucleic acid and polypeptide with homology to the tnf-receptors |
| 07/08/1999 | WO1999033963A1 Metastatic cancer regulated gene |
| 07/08/1999 | WO1999033962A1 HUMAN CYCLIN-DEPENDENT KINASE (hPFTAIRE) |
| 07/08/1999 | WO1999033961A1 Novel kinase |
| 07/08/1999 | WO1999033958A2 Desaturase |
| 07/08/1999 | WO1999033877A1 V196 dna and polypeptides |
| 07/08/1999 | WO1999033876A1 Novel seven-pass transmembrane receptor protein |
| 07/08/1999 | WO1999033875A1 Compounds and methods for modulating synaptic stability |
| 07/08/1999 | WO1999033873A1 NOVEL POLYPEPTIDES, cDNAS ENCODING THE SAME AND UTILIZATION THEREOF |
| 07/08/1999 | WO1999033872A1 Novel anti-hiv immunogens (toxoids), preparation methods and use for preventing and treating aids |
| 07/08/1999 | WO1999033870A2 Human regulatory proteins |
| 07/08/1999 | WO1999033869A2 Compounds for immunotherapy and diagnosis of breast cancer and methods for their use |
| 07/08/1999 | WO1999033868A2 Human papillomavirus vaccine |
| 07/08/1999 | WO1999033866A2 Antivirally active oligopeptide isolated from royal jelly |
| 07/08/1999 | WO1999033865A1 Contryphan peptides |
| 07/08/1999 | WO1999033864A1 Peptide derivatives |
| 07/08/1999 | WO1999033863A1 Peptide chelators that predominately form a single stereoisomeric species upon coordination to a metal center |
| 07/08/1999 | WO1999033853A2 Carbohydrates, useful in solid delivery systems |
| 07/08/1999 | WO1999033849A1 Prodrugs of naaladase inhibitors |
| 07/08/1999 | WO1999033847A1 Phosphinic alkanoic acid derivatives |
| 07/08/1999 | WO1999033818A1 Vitamin e derivatives |
| 07/08/1999 | WO1999033801A1 Tripeptidyl peptidase inhibitors |
| 07/08/1999 | WO1999033787A1 Amino acid derivatives |
| 07/08/1999 | WO1999033488A2 Adjuvanted vaccine formulation |
| 07/08/1999 | WO1999033487A1 Immunosuppressant agonists |
| 07/08/1999 | WO1999033486A1 Composition and method for dermal and transdermal administration of a cytokine |
| 07/08/1999 | WO1999033485A1 Expression vectors and cell lines expressing vascular endothelial growth factor d, and method of treating melanomas |
| 07/08/1999 | WO1999033484A1 Production process for intravenous immune serum globulin and resultant product |
| 07/08/1999 | WO1999033483A1 Trialkyl-lock-facilitated polymeric prodrugs of amino-containing bioactive agents |
| 07/08/1999 | WO1999033482A1 Uses of alpha-conotoxin peptides |
| 07/08/1999 | WO1999033481A2 Process using the growth factor igf-i in the manufacture of compositions that are useful in the treatment of cerebellar ataxia |
| 07/08/1999 | WO1999033415A1 Osteopontin-based compositions for enhancing bone repair |
| 07/08/1999 | WO1999033346A1 Anti-retroviral immunogens, preparation and use |
| 07/08/1999 | WO1999033342A1 Method of suppressing tumor cell growth by administering decorin |
| 07/08/1999 | WO1999023109A3 A method for mapping the active sites bound by enzymes that covalently modify substrate molecules |
| 07/08/1999 | WO1999021994A3 Human vesicle membrane protein-like proteins |
| 07/08/1999 | WO1999021887A3 Method for the production of human blood cytokines |
| 07/08/1999 | WO1999021574A3 Enhancement of morphogen activity |
| 07/08/1999 | WO1999019466A3 Thymidine kinase mutants and fusion proteins having thymidine kinase and guanylate kinase activities |
| 07/08/1999 | WO1999016406A3 Therapeutic method |
| 07/08/1999 | WO1999015662A9 Telomere repeat binding factors and diagnostic and therapeutic use thereof |
| 07/08/1999 | WO1999014357A9 Reagents and methods useful for detecting diseases of the prostate, breast and ovary |
| 07/08/1999 | WO1999014231A3 Bifidus stimulating peptides and its uses |
| 07/08/1999 | WO1999011794A3 New vrk1 kinase |
| 07/08/1999 | WO1999011606A3 Inhibitors of protein tyrosine phosphatase |